Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Net Income Loss of -$6.12 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +84.8% in Net Income Loss from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$4.75 million | Q3 2013: -$4.88 million | Q1 2014: -$4.07 million | Q2 2014: -$2.47 million | Q3 2014: -$11.02 million | Q1 2015: -$7.14 million | Q2 2015: -$6.94 million | Q3 2015: -$6.62 million | Q4 2015: -$7.75 million | Q1 2016: -$10.99 million | Q2 2016: -$10.15 million | Q3 2016: -$11.57 million | Q4 2016: -$11.55 million | Q1 2017: -$13.93 million | Q2 2017: -$13.60 million | Q3 2017: -$12.27 million | Q4 2017: -$3.01 million | Q1 2018: -$16.25 million | Q2 2018: -$26.81 million | Q3 2018: -$21.54 million | Q4 2018: -$26.16 million | Q1 2019: -$27.05 million | Q2 2019: -$18.50 million | Q3 2019: -$25.00 million | Q4 2019: -$27.08 million | Q1 2020: -$26.66 million | Q2 2020: $7.27 million | Q3 2020: -$3.35 million | Q4 2020: -$39.42 million | Q1 2021: -$27.20 million | Q2 2021: -$23.60 million | Q3 2021: -$18.80 million | Q1 2022: -$23.09 million | Q2 2022: -$24.46 million | Q3 2022: -$23.15 million | Q1 2023: -$18.95 million | Q2 2023: -$16.90 million | Q3 2023: -$14.42 million | Q1 2024: -$9.08 million | Q2 2024: -$11.15 million | Q3 2024: -$9.61 million | Q1 2025: -$8.82 million | Q2 2025: -$10.20 million | Q3 2025: -$9.20 million.
- Over the full 19 years of available data (2007 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Net Income Loss has declined by 34.0%.
- Historical annual values: Fiscal year 2025: -$6.12 million | Fiscal year 2024: -$40.18 million | Fiscal year 2023: -$61.23 million | Fiscal year 2022: -$93.09 million | Fiscal year 2021: -$129.86 million | Fiscal year 2020: -$62.15 million | Fiscal year 2019: -$97.63 million | Fiscal year 2018: -$90.75 million | Fiscal year 2017: -$42.81 million | Fiscal year 2016: -$44.26 million | Fiscal year 2015: -$28.45 million | Fiscal year 2014: -$23.79 million | Fiscal year 2013: -$19.40 million | Fiscal year 2012: -$24.79 million | Fiscal year 2011: -$34.34 million | Fiscal year 2010: -$15.29 million | Fiscal year 2009: -$4.54 million | Fiscal year 2008: -$8.79 million | Fiscal year 2007: -$4.57 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: